1980-1997, the rate of twin births among white mothers increased at a rate nearly twice that of black mothers (5) . Although multiple gestations increase the risk for LBW and VLBW births, LBW rates are higher among singleton infants conceived with assisted reproductive technology (6) . Nevertheless, blacks continue to have a two-to threefold higher risk than whites for LBW and VLBW. In 1991, >66% of the black-white racial disparity in infant mortality occurred among VLBW infants (7) . The specific causes for increased low birth weight and preterm delivery might differ for blacks and whites. The etiology of black-white disparities in low birth weight is complex and is not explained entirely by demographic risk factors such as maternal age, education, or income (8) . Factors that might contribute to the disparity include racial differences in maternal medical conditions, stress, lack of social support, bacterial vaginosis, previous preterm delivery, and maternal health experiences that might be unique to black women (9) .
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Of additional concern are disparate improvements in BWSMRs for blacks and whites over time. During the 1980s, BWSMRs for black VLBW infants were lower than for white VLBW infants. Although these differences are poorly understood, the relative advantage of lower BWSMRs among VLBW blacks has disappeared. Because BWSMRs are influenced by access to quality obstetric and neonatal care, particularly among VLBW births, differential access might exist for blacks compared with whites. Declines in neonatal mortality because of improvements in treatment for specific medical disorders (e.g., respiratory distress syndrome) have been greater for whites than for blacks (10) .
The findings of this report are subject to at least three limitations. First, infant mortality was calculated by using the race of the infant as the numerator and the race of the mother as the denominator, and might differ slightly from total BWSMRs. This number might affect calculations of infant mortality in which the race of the mother and that of the infant are reported as different. Second, linked data from 1983 are the earliest linked birth infant death data by race of mother and were not available for 1980-1982 and 1992-1994 . Finally, vital records data contain mostly demographic information and do not explain specific reasons for racial disparities in outcomes. Studies that examine quality of health-care delivery, specific maternal and neonatal interventions, and social and environmental determinants might identify the reasons for these differences.
Prevention strategies must focus on reducing LBW and VLBW births to eliminate racial disparities in infant mortality. During the last decade, these disparities have decreased, not because of reductions in LBW births among blacks but because of increases in LBW births among whites. Research should be aimed at preventing preterm delivery and associated factors (e.g., infection, medical complications of pregnancy, or poor prenatal care), and the promotion of effective and culturally sensitive intervention programs (9) . Strategies to reduce black-white disparities also should address disparate reductions in specific medical conditions that lead to infant death.
Update: AIDS -United States, 2000
Since the implementation of highly active antiretroviral therapy (HAART) in the United States in 1996, the number of persons diagnosed with acquired immunodeficiency syndrome (AIDS) and the number of deaths among persons with AIDS have declined substantially (1) ; as a result, the number of persons living with AIDS has increased. This report describes changes in AIDS incidence, prevalence, and deaths among persons with AIDS during January 1996-December 2000. Surveillance data indicate a slowing of declines in new AIDS diagnoses, continued declines in deaths among persons with AIDS, and increases in the number of persons living with AIDS. These findings indicate that AIDS continues to place a burden on the health-care system in the United States and that access to medical and preventive services must be improved to reduce the public health impact of AIDS.
AIDS surveillance is conducted in all states, the District of Columbia, and U.S. territories; cases are reported to CDC by using a standard definition and form. In addition, most states conduct human immunodeficiency virus (HIV) surveillance (2) . To estimate AIDS incidence and deaths of persons with AIDS through December 2000, CDC adjusted reported cases for reporting delays (3) . The HIV-exposure categories for cases reported initially without risk were estimated from historical patterns of risk ascertainment and reclassification. AIDS prevalence was estimated by subtracting cumulative deaths from cumulative AIDS incidence (4) .
AIDS incidence increased rapidly throughout the 1980s, peaked in the early 1990s, and then declined (Figure 1 ). The peak of new diagnoses in 1993 was associated with expansion of the AIDS surveillance case definition (5) . In 1996, sharp declines in AIDS incidence were observed for the first time; during 1998-1999, declines in AIDS incidence began to level. During 1999-2000, essentially no change in AIDS incidence was observed; an estimated 40,907 new AIDS cases were diagnosed in 1999 and an estimated 41,113 in 2000. During 1996-2000, AIDS incidence declined in the West; declined and then leveled in the South, Midwest, and U.S. territories; and declined and then increased in the Northeast. During the same period, AIDS incidence declined sharply and then slowed among whites and declined more slowly and then leveled among blacks, Hispanics, and Asians/ Pacific Islanders; during 1998-1000, incidence increased among American Indians/ Alaska Natives from 152 in 1998 to 183 in 2000 (4) . AIDS incidence declined sharply and then slowed among men who have sex with men (MSM) and injection-drug users (IDUs); incidence continued to decline among MSM who also were IDUs. Among persons exposed through heterosexual contact, incidence declined slowly during 1996-1998 and then increased from 10,258 in 1999 to 11,136 in 2000 ( Figure 2 ).
During 1996-1997, the estimated number of deaths among persons with AIDS declined 42%; during 1998-2000, declines were smaller (5% during 1998-1999 and 10% during 1999-2000) (Table) . During 1996-2000, the number of deaths declined in the Northeast, West, and Midwest; during 1996-1999, deaths declined in the South and U.S. territories, and then leveled during 1999-2000. The number of deaths declined in all racial/ethnic groups and among MSM, male and female IDUs, and MSM/IDUs. During 1996-1998, the number of deaths among men and women with AIDS attributed to heterosexual contact declined and then leveled during 1999-2000 (Table) .
AIDS prevalence has increased steadily over time; as of December 31, 2000, an estimated 337,731 persons in the United States were living with AIDS ( Figure 1 ). Of these, an estimated 139,522 (41%) were black, 127,838 (38%) white, 65,991 (20%) Hispanic, 2,841 (1%) Asians/Pacific Islanders, and 1,180 (<1%) American Indians/Alaska Natives. An estimated 129,333 (38%) lived in the South, 99,482 (29%) in the Northeast, 66,085 (20%) in the West, 32,909 (10%) in the Midwest, and 9,922 (3%) in U.S. territories. Of the estimated 264,149 adult and adolescent (i.e., person aged >13 years) males living with AIDS, approximately 151,325 (57%) were MSM, 64,522 (24%) were IDUs, and 20,528 (8%) were MSM/IDUs; 23,333 (9%) were exposed through heterosexual contact. Of the estimated 69,775 adult and adolescent women living with AIDS, 40,051 (57%) were exposed through heterosexual contact, and 27,475 (39%) were IDUs. An estimated 3,807 children aged <13 years were living with AIDS; of these, approximately 90% were infected perinatally. 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 Editorial Note: During 1996-2000, AIDS incidence declined or leveled in most geographic regions and among most racial/ ethnic groups and HIV-exposure categories; incidence increased slightly among persons exposed heterosexually and among persons living in the Northeast (4). Although the number of deaths among persons with AIDS declined during 1996-2000, the magnitude of decline varied by region and exposure category; the number of deaths declined among persons with AIDS in all racial/ethnic groups. Declines in AIDS incidence and deaths are associated primarily with the widespread use of HAART, which slows progression of HIV infection to AIDS and of AIDS to death (1, 6 and preventing morbidity and mortality among persons living with HIV.
As of December 2000, an estimated 340,000 persons in the United States were living with AIDS. Increasing proportions of persons living with AIDS are black or Hispanic, female, residents of the South, and persons exposed to HIV through heterosexual contact. This finding is consistent with other studies that indicate HIV and AIDS affect disproportionately subgroups that traditionally have had limited access to medical and preventive services because of poverty and social disadvantage (1). This is particularly important for interpreting trends in AIDS because access to high-quality medical services facilitates early treatment of HIV infection and can delay the onset of AIDS. Many persons in historically disadvantaged groups might lack access to or not seek adequate health-care services. An estimated one fourth of persons living with HIV in the United States are not aware of their infection and their need for services, and one third of persons who are aware of their infection are not receiving care (7) . Efforts to meet the preventive service and health-care needs of persons living with HIV/AIDS are imperative to improving their Before advances in therapy, public health surveillance of acquired immunodeficiency syndrome (AIDS) provided reliable population-based information that represented trends in the incidence of human immunodeficiency virus (HIV) infection. However, since 1996, highly active antiretroviral therapy (HAART) has prolonged substantially the interval between the diagnosis of HIV infection and the development of AIDS, which has diminished the capacity of AIDS surveillance alone to monitor the underlying patterns of HIV transmission (1). As a result, CDC recommends that states conduct HIV-infection reporting in addition to AIDS surveillance (2) . This report describes trends in newly diagnosed cases of HIV infection in 25 states* that conducted name-based HIV/AIDS surveillance during 1994-2000 (3). The findings indicate that the number of diagnosed HIV infections declined in these states during 1994-1997 and remained constant during 1998-2000. HIV/AIDS surveillance should be conducted by all states to fully characterize persons infected with HIV who need treatment and prevention services.
Since 1994, CDC has supported uniform HIV surveillance for all 50 states and territories. The 25 states included in this analysis have collected HIV surveillance data since 1994 and submitted case reports to CDC after removal of personal identifiers (3). Cases were divided into two categories: persons in whom HIV infection was diagnosed without an AIDS diagnosis and persons in whom HIV infection was diagnosed when AIDS was diagnosed (4). Data with or without AIDS were analyzed by the earliest date of diagnosis of HIV for 1994-2000. HIV/AIDS data were adjusted for delays in reporting of cases and deaths. Estimates for the mode of exposure were adjusted for anticipated reclassification of cases reported originally without this information (5) .
During 1994-2000, HIV infection was diagnosed in 128,813 persons in the 25 states. Of these, the initial diagnosis was HIV infection with AIDS in 33,144 (26%) and HIV infection without AIDS in 95,699 (74%) (Table) . The number of persons in whom HIV infection without AIDS was the initial diagnosis declined 21% (from 15,945 in 1994 to 12,612 in 2000), and the number of persons in whom HIV infection with AIDS was the initial diagnosis declined 31% (from 5,760 in 1994 to 3,987 in 2000). However, during 1998-2000, the number of diagnosed cases of HIV infection with and without AIDS remained constant (Table) .
During 1994-2000, the proportion of persons in whom HIV infection with AIDS was newly diagnosed remained relatively stable (27% in 1994 and 24% in 2000). However, the proportion of HIV-infected persons who also had AIDS varied by demographic subgroup and mode of exposure. Persons with AIDS at the time of initial HIV diagnosis were more likely to be male and older (Table) . Asians/Pacific Islanders (34%), non-Hispanic whites (29%), and Hispanics (29%) were more likely than non-Hispanic blacks (23%) and American Indians/Alaska Natives (22%) to have AIDS at the time of initial HIV diagnosis. Of the 128,813 HIV infections with and without AIDS, the majority of newly diagnosed HIV infections were among non-Hispanic blacks (70,990 [55%]). When evaluated by mode of exposure, men who have sex with men (MSM) accounted for the largest proportion (15,694 [47%]) of persons with AIDS at the time of initial HIV diagnosis, followed by persons exposed through injection-drug use (IDU) (7,913 [24%] ).
Trends in the number of persons who had HIV infection newly diagnosed with and without AIDS varied substantially Editorial Note: Surveillance data on HIV and AIDS facilitates a more complete assessment of HIV transmission patterns. Surveillance data on HIV diagnoses with and without AIDS from these 25 states indicate that during 1994-2000, the number of persons in whom HIV infection was newly diagnosed declined during 1994-1997 and then stabilized during 1998-2000. The majority of the decline occurred among persons aged 25-44 years. Persons in this age group were affected more by the epidemic during the 1980s and 1990s; accordingly, these decreases probably reflect the declines from the peak incidence during the late 1980s (1) . The stabilization of case counts in every age group during 1999-2000 suggests that earlier declines in newly diagnosed HIV infections have abated. These trends should continue to be monitored, and surveillance systems that collect information systematically on newly diagnosed HIV infections should be expanded to other states to characterize persons needing treatment and prevention services (3) .
Trends in the number of HIV diagnoses can be influenced by changes in testing patterns for HIV and increases or decreases in HIV transmission. Data from national surveys and publicly funded counseling and testing sites indicate that testing rates have remained relatively unchanged during the late 1990s (2, 6) . HIV-infection surveillance will be facilitated by new technologies that can identify patients infected recently (i.e., <6 months) (7) . CDC is initiating activities to integrate these new laboratory technologies into routine HIVinfection surveillance.
A total of 33 states have name-based HIV-infection reporting. An additional 14 states have instituted non-name or codebased reporting of diagnosed HIV infections. Variable combinations of information about the patient (e.g., portions of the name, birth date, sex, and race) are used to create the codes so reports about the patient can be linked to avoid duplicate reporting and to follow clinical outcomes over time. Systems that use name-based reporting of AIDS are at least 90% complete (8) . On the basis of performance guidelines for HIV-infection reporting, CDC is assisting states to assess the completeness, timeliness, validity, and usefulness of nameand code-based reporting systems (2) .
The findings in this report are subject to at least three limitations. First, a limited number of states were included in this analysis; 24% of all AIDS cases diagnosed in the United States during 1994-2000 occurred in the 25 states. Second, the reporting on mode of exposure has become more incomplete during the surveillance period; therefore, analysis of mode of exposure requires greater statistical adjustment. Verification of the validity of these modeled estimates can be achieved by sampling a subset of representative cases for intensive followup. Third, HIV reporting might be incomplete, and duplicate reporting of persons in whom HIV infection was first diagnosed in one state and who are then diagnosed with AIDS in another state might be occurring.
The proportion of HIV-infected persons who had HIV diagnosed at time of AIDS diagnosis remained relatively constant in these states. An estimated 25% (180,000-280,000 persons) of HIV-infected persons in the United States are not aware of their serostatus (9) . The majority of infections were diagnosed in non-Hispanic blacks, and a substantial number were reported in Hispanics. HIV affects disproportionately populations that traditionally have limited access to or use of medical and preventive services because of socioeconomic disadvantage and other factors (1). If HIV-testing strategies had effectively penetrated into high-risk populations (e.g., at-risk racial/ethnic minorities and young MSM) during this surveillance period, a substantially smaller proportion of the HIV diagnoses would have been identified with AIDS. A CDC 
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Weekly Update: West Nile Virus Activity -United States, July 3-9, 2002
This report summarizes West Nile virus (WNV) surveillance data reported to CDC through ArboNET and verified by states and other jurisdictions as of July 9, 2002 .
During the reporting week of July 3-9, the first verified human case of WNV encephalitis in 2002 was reported from Louisiana in a man aged 78 years. During the same period, WNV infections were reported in 31 dead crows, 75 other dead birds, seven sentinel chicken flocks, four horses, one wild bird that was caught and released, and one mosquito pool.
During 2002, in addition to the one human case of WNV encephalitis, a total of 116 dead crows and 151 other dead birds with WNV infection were reported from 18 states and the District of Columbia (Figure) ; 14 WNV infections in horses were reported from three states (Florida, Kentucky, and Louisiana). During 2002, WNV seroconversions were reported in 10 sentinel chicken flocks from Florida; WNV seropositivity was reported from two states (Indiana and Louisiana) in two wild birds that were caught and released; and seven WNV-positive mosquito pools were reported from three states (Illinois, New Jersey, and Ohio).
Additional information about WNV activity is available at http://www.cdc.gov/ncidod/dvbid/westnile/index.htm and http://cindi.usgs.gov/hazard/event/west_nile/west_nile.html.
Notice to Readers

Resumption of Routine Schedule for Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine and for Measles, Mumps, and Rubella Vaccine
Supplies of diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine and measles, mumps, and rubella (MMR) vaccine in the United States have become sufficient to permit the resumption of the routine schedule for DTaP and MMR use as recommended by the Advisory Committee on Immunization Practices (ACIP) (1-3) . However, healthcare providers should be advised that, for the next 2 months, 
MMR Vaccine
A temporary shortage of MMR vaccine in the United States resulted from a voluntary interruption of manufacturing operations of Merck & Co., Inc., the only manufacturer of this vaccine in the United States (7). During the vaccine shortage, ACIP recommended deferral of the second dose of MMR vaccine at age 4-6 years if health-care providers were unable to obtain sufficient amounts of vaccine. The first dose at age 12-15 months was not to be delayed because of the severity of measles in young children (7) . Supplies are now adequate to resume the second dose of MMR vaccine (2,3).
Vaccine Supply
Health-care providers should review the vaccination status of their patients and administer DTaP and MMR vaccines, as appropriate. For at least the next 2 months, providers should order DTaP and MMR vaccine in amounts sufficient for a <30-day supply to ensure that current supplies can meet requests. Recall or special initiative programs can be instituted when DTaP and MMR vaccine supply improves further but should be deferred during this transition period. However, if children who need these vaccines seek medical care for other reasons, they should be administered vaccine provided no contraindications exist. Furthermore, vaccine should be offered to children who need vaccination and whose parents requested vaccination. CDC will continue to monitor DTaP and MMR vaccine supply and, if necessary, allocate vaccine. Updates regarding vaccine supply and shortages can be found at http://www.cdc.gov/nip/. 
